Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00852553 · ClinicalTrials.gov registry record

Neurohumoral Control of Intestinal Electrical and Mechanical Activity

A clinical trial of Morbid Obesity, sponsored by University of California, Davis.

Completed
Registry status
45
Enrollment target
2
Study locations

NCT00852553: Completed study of Morbid Obesity, sponsored by University of California, Davis.

NCT00852553 is a study of Morbid Obesity that has completed, run by University of California, Davis. The registered enrollment target is 45 participants, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (62% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00852553, a study of Morbid Obesity, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
45 participants
Enrollment target
2
Study locations

Study Summary

A collaborative research project with Dr. Kathleen Keef (Department of Physiology, University of Nevada School of Medicine, Reno, Nevada) studying the role of putative neurotransmitters in human intestine.

Conditions Studied

Study Locations (2)

California

  • University of California, Davis Medical Center - Sacramento

Nevada

  • University of Nevada School of Medicine - Reno

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2003-02
Est. Completion 2012-02
University of California, Davis

657 total trials

What the finished NCT00852553 record still lists

NCT00852553 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 120-participant average among 24 other Morbid Obesity trials with a reported enrollment target (62% lower).

The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT00852553 reports a single indexed study location in California, Nevada.

Frequently Asked Questions

What is clinical trial NCT00852553 about?

NCT00852553 is a clinical study titled "Neurohumoral Control of Intestinal Electrical and Mechanical Activity". A collaborative research project with Dr. Kathleen Keef (Department of Physiology, University of Nevada School of Medicine, Reno, Nevada) studying the role of putative neurotransmitters in human intestine.

What is the current status of trial NCT00852553?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2003-02. Estimated completion is 2012-02.

What conditions does trial NCT00852553 study?

This clinical trial studies the following conditions: Morbid Obesity.

Who is sponsoring clinical trial NCT00852553?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00852553 being conducted?

This trial has 2 study locations across California, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Morbid Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00852553's enrollment target sits among peer trials

45 19th of 24 higher than 6 of 24 other Morbid Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00852553, the US trial registry maintained by the National Library of Medicine. NCT00852553 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.